Skip to main content

Dr Emil Bujak

Advisor to HBM Partners

Over ten years of experience in venture capital and medicinal research. Prior experience as a registered pharmacist, and in antibody technology research at Philogen. Holds a PhD and an MSc in Medicinal and Industrial Pharmaceutical Sciences from ETH Zurich and is a Chartered Financial Analyst (CFA) since 2019. Board member of Polyneuron, board observer at Pyxis Oncology.

Back
Dr Emil Bujak